Alternatives to argenx
argenx is a BiTech tool: global immunology company developing antibody-based therapies for severe autoimmune diseases. Here are the 60 closest alternatives, compared on pricing, features and what real users say.
The 20 closest BiTech companies to argenx
- Website
Viridian Therapeutics, Inc.43BiotechnologyWaltham, United States$350.0MBiopharmaceutical company developing best-in-class medicines for autoimmune and rare diseases, with a focus on thyroid eye disease.
- Website
Infinimmune60BiotechnologyAlameda, United States$75.0MDeveloping human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.
- Website
Janux Therapeutics57BiotechnologySan Diego, USA$181.0MA clinical-stage biopharmaceutical company developing novel immunotherapies.
- EAEarendil Labs56BiotechnologyBeijing, China$787.0M
Earendil Labs is an AI biotechnology company focused on leveraging artificial intelligence for drug discovery and development of next-generation biologics.
- Website
Alector55BiotechSouth San Francisco, United States$162.5MBiotechnology company developing immuno-neurology therapies for neurodegenerative diseases.
- Website KHKhartis Therapeutics, Inc.53BiotechnologySan Diego, United States$50.0M
Developing oral small molecule medicines for immunological and chronic diseases.
- Website
Immix Biopharma, Inc.51BiotechnologyLos Angeles, United States$5.0MA clinical-stage biopharmaceutical company developing novel cell therapies for AL Amyloidosis and other serious diseases.
- Website
LTZ Therapeutics49BiotechnologyRedwood City, USA$76.0MImmunotherapy company targeting oncology and autoimmune diseases.
- Website
Dren Bio48BiotechSan Carlos, United States$156.0MBiopharmaceutical company developing antibody therapeutics for cancer and autoimmune diseases.
- Website
Alchemab Therapeutics42BiotechnologyLondon, United Kingdom$31.5MDiscovering and developing first-in-class antibody therapeutics by identifying protective antibodies from disease-resilient individuals.
- Website
Tubulis58BiTechMunich, Germany$436.5MDevelops antibody-drug conjugates (ADCs) for targeted cancer therapy.
- Website
Moderna77BiotechnologyCambridge, United States$4.5BModerna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
- Website
Immunai69HealthcareNew York, United States$295.0MMapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.
- Website
Adaptive Biotechnologies69BiotechSeattle, United States$300.0MLeveraging the adaptive immune system to diagnose and treat disease.
- Website
CytoReason68HealthcareTel Aviv, Israel$128.3MDevelops a computational model of the human body for drug discovery and development.
- Website
BeiGene64BiotechCambridge, United States$358.0MA global oncology company developing and commercializing innovative cancer treatments.
- Website
Cue Biopharma, .62BiotechBoston, United States$10.0MDeveloping engineered biologics to harness the immune system for disease treatment.
- Website
Degron Therapeutics62BiotechnologySan Diego, USA$40.0MClinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.
- Website
Upstream Bio61Life SciencesWaltham, United States$400.0MClinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.
- Website
Immunyx Pharma46Life SciencesNew York, United StatesBiopharmaceutical company developing targeted neutrophil nanoparticle platform for chronic diseases.
Showing the 20 closest matches. See the rest on the argenx profile.
Compare argenx head to head
Side by side on what each one does, what it costs, and what real users report.